HLA-DR11 antigen

Also Known As:

HLA DR11 antigen; HLA DRw11; HLA-DRw11; HLA-DRw11 antigen; HLA-Dr11

Networked: 27 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR Serological Subtypes
        HLA-DR11 antigen: 27

Experts

1.	Ahmed, Mona A: 2 articles (04/2004 - 04/2004)
2.	Azab, Magda E: 2 articles (04/2004 - 04/2004)
3.	Bishara, Sawsan A: 2 articles (04/2004 - 04/2004)
4.	El-Hoseiny, Laila M: 2 articles (04/2004 - 04/2004)
5.	Oteifa, Nihad M: 2 articles (04/2004 - 04/2004)
6.	Chen, Shin-Fan: 1 article (10/2015)
7.	Chu, Chen-Chung: 1 article (10/2015)
8.	Dai, Ciou-Sia: 1 article (10/2015)
9.	Lee, Chin-Chan: 1 article (10/2015)
10.	Lin, Marie: 1 article (10/2015)

Related Diseases

1.	Chronic Kidney Failure (Chronic Renal Failure) 10/30/2015 - "The current work suggests that HLA-DR3 (odds ratio = 1.91, 95 % CI = 1.098-3.324, P = 0.024, Pc = 0.312) and HLA-DR11 (odds ratio = 2.06, 95 % CI = 1.133-3.761, P = 0.021, Pc = 0.273) may represent susceptibility risk factors for the development of ESRD in Taiwanese individuals. " 06/01/2008 - "The antigens positively associated with ESRD were: HLA-A78 (RR = 30.31 and EF = 0.96) and HLA-DR11 (RR = 18.87 and EF = 0.65). " 09/01/2014 - "While the HLA-B8 antigen may be a susceptibility risk factor for development of ESRD, the HLA-A28, and HLA-DR11 antigens may be protective against development of ESRD in Kuwaiti population." 09/01/2014 - "The frequency of HLA-B8 antigen was significantly higher in ESRD patients (OR = 2.62, p = 0.001, pc = 0.038), and the frequency of HLA-A28, HLA-DR11 antigens was significantly higher in healthy controls (OR 0.42, p = 0.0001; pc = 0.0021, and OR = 0.44, p = 0.0007, pc = 0.01 respectively). "
2.	Infections 03/15/2004 - "In conclusion, HLA-DR11 seems to be protective against the development of severe forms of infection, and the DR3/MICA-A4/B18 haplotype may be an important factor in the progression to the most severe HCV-infection status." 01/15/2003 - "Patients carrying the HLA-A11, HLA-A32, or HLA-DR11 allele developed active infection more frequently, whereas none of the patients with the HLA-B16 or HLA-B55 allele was actively infected. " 08/01/2008 - "We found different acute CMV infection distribution in the careers and non-careers of investigated HLA-types: HLA-A2, HLA-B12, HLA-Cw7, HLA-DR6 and HLA-DR11, but the differences were not significant in these HLA-types (P = 0.26, P = 0.37, P = 0.83, P = 0.07 and P = 0.37). "
3.	Non-Radiographic Axial Spondyloarthritis 11/01/2023 - "The key findings of our study are the newly detected findings of HLA typing beyond HLA-27 positivity: HLA-DR16 in AS, HLA-DR11 in nr-axSpA, HLA-B13, HLA-B57, HLA-Cw12 and HLA-DR7 in r-axPsA, and HLA-B18 in nr-axPsA. "
4.	Human Influenza (Influenza) 10/15/1991 - "We have identified the site encompassing residues 126-145 on the A/Japan/57 influenza hemagglutinin molecule that is recognized in association with HLA-DRw11 by a clonal population of human, influenza specific, CD4+ cytolytic T lymphocytes. " 02/01/1994 - "To explore the possibility that peptide loading of class II molecules was occurring after endocytosis of peptides as well as by surface binding, we utilized an immunogenic hemagglutinin peptide (HAP 128-145) from the influenza strain A/Japan/57, and studied the appearance of surface complexes of HAP 128-145 bound to HLA-DRw11 molecules on human B-lymphoblastoid cells (BLCLs). "
5.	End Stage Liver Disease 03/15/2004 - "The frequency of HLA-DR11 was increased in HCV carriers, compared with patients with end-stage liver disease (ESLD) (corrected P value [Pc],.0002) and, especially, with patients who had HCC (Pc=.003). "

Related Drugs and Biologics

1.	Antigens
2.	HLA-B8 Antigen (HLA B8 Antigen)
3.	HLA-A28 antigen
4.	mica
5.	HLA-B18 Antigen
6.	HLA-B13 Antigen
7.	HLA-DR7 Antigen (HLA DR7 Antigen)
8.	HLA-C*12 antigen
9.	HLA-B57 antigen
10.	HLA-DR16 antigen

Related Therapies and Procedures

1.	Hematopoietic Stem Cell Transplantation